Postmenopausal Hormone Therapy
- 1 November 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 106 (5, Part 1), 940-945
- https://doi.org/10.1097/01.aog.0000180394.08406.15
Abstract
OBJECTIVE: To estimate the effect of hormone therapy on risk of stress and urge urinary incontinence. METHODS: The Heart Estrogen/progestin Replacement Study was a randomized, placebo-controlled, double-blinded trial to evaluate daily oral conjugated estrogen (0.625 mg) plus medroxyprogesterone acetate (2.5 mg) therapy for the prevention of heart disease events in women with established heart disease. The 1,208 participants in Heart Estrogen/progestin Replacement Study who reported no loss of urine in the previous 7 days at baseline are included in this analysis. RESULTS: During 4.2 years of treatment, 64% of women randomly assigned to hormone therapy compared with 49% of those assigned to placebo reported weekly incontinence (P < .001). The higher risk of incontinence in the hormone group was evident at 4 months, persisted throughout the treatment period, and was independent of the age of the women. The odds ratios for weekly incontinence among women on hormone therapy compared with placebo were 1.5 for urge incontinence (95% confidence interval [CI] 1.2–1.8; P < .001) and 1.7 for stress incontinence (95% CI 1.5–2.1; P < .001). Four years of treatment with hormone therapy caused an excess risk of 12% for weekly urge incontinence and 16% for weekly stress incontinence; the corresponding numbers needed to harm were 8.6 (95% CI 5.8–16.6) and 6.2 (95% CI 4.6–9.4). CONCLUSION: Estrogen plus progestin therapy increases risk of urge and stress incontinence within 4 months of beginning treatment. LEVEL OF EVIDENCE: IKeywords
This publication has 37 references indexed in Scilit:
- Effects of Estrogen With and Without Progestin on Urinary IncontinencePublished by American Medical Association (AMA) ,2005
- The Effect of Ovariectomy and Estradiol on Rabbit Bladder Smooth Muscle Contraction and MorphologyJournal of Urology, 2003
- The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinenceBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigationBJOG: An International Journal of Obstetrics and Gynaecology, 2001
- The pelvic floor muscles: Muscle thickness in healthy and urinary-incontinent women measured by perineal ultrasonography with reference to the effect of pelvic floor training. Estrogen receptor studiesNeurourology and Urodynamics, 1997
- Efficacy of estrogen supplementation in the treatment of urinary incontinenceObstetrics & Gynecology, 1996
- Clinical outcome and changes in connective tissue metabolism after intravaginal slingplasty in stress incontinent womenInternational Urogynecology Journal, 1996
- Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkeyNeurourology and Urodynamics, 1996
- Changes in Urethral Cytology following Estrogen AdministrationGynecologic and Obstetric Investigation, 1990
- Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1987